Drug Type Monoclonal antibody |
Synonyms INT 119, INT119 |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Intract Pharma Ltd.Startup |
Active Organization Intract Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 1 | - | Intract Pharma Ltd.Startup | - |
Crohn Disease | Phase 1 | - | Intract Pharma Ltd.Startup | - |